The JMJD3 Histone Demethylase and the EZH2 Histone Methyltransferase in Prostate Cancer

OMICS. 2016 Feb;20(2):123-5. doi: 10.1089/omi.2015.0113.

Authors

Marine Daures^{1

2}, Marjolaine Ngollo^{1

2}, Gaëlle Judes^{1

2}, Khaldoun Rifaï^{1

2}, Jean-Louis Kemeny³, Frédérique Penault-Llorca^{1

2}, Yves-Jean Bignon^{1

2}, Laurent Guy^{2

4}, Dominique Bernard-Gallon^{1

2}

Affiliations

¹ 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France .
² 2 EA 4677 "ERTICA", University of Auvergne , Clermont-Ferrand, France .
³ 3 Department of Pathology, Gabriel Montpied Hospital , Clermont-Ferrand, France .
⁴ 4 Department of Urology, Gabriel Montpied Hospital , Clermont-Ferrand, France .

PMID: 26871869
DOI: 10.1089/omi.2015.0113

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / enzymology*
Adenocarcinoma / pathology
Biomarkers, Tumor / genetics
Biomarkers, Tumor / metabolism*
Cell Line, Tumor
Enhancer of Zeste Homolog 2 Protein
Gene Expression
Humans
Jumonji Domain-Containing Histone Demethylases / genetics
Jumonji Domain-Containing Histone Demethylases / metabolism*
Male
Neoplasm Grading
Polycomb Repressive Complex 2 / genetics
Polycomb Repressive Complex 2 / metabolism*
Promoter Regions, Genetic
Prostatic Neoplasms / enzymology*
Prostatic Neoplasms / pathology
Receptors, Retinoic Acid / genetics

Substances

Biomarkers, Tumor
RARB2 protein, human
Receptors, Retinoic Acid
Jumonji Domain-Containing Histone Demethylases
KDM6B protein, human
EZH2 protein, human
Enhancer of Zeste Homolog 2 Protein
Polycomb Repressive Complex 2